Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders
Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration....
Ausführliche Beschreibung
Autor*in: |
Pagin, A. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020transfer abstract |
---|
Schlagwörter: |
CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Cystic fibrosis transmembrane conductance regulator (CFTR) |
---|
Umfang: |
5 |
---|
Übergeordnetes Werk: |
Enthalten in: Archives de pédiatrie - Cui, Yuqiong ELSEVIER, 2021, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:27 ; year:2020 ; pages:25-29 ; extent:5 |
Links: |
---|
DOI / URN: |
10.1016/S0929-693X(20)30047-6 |
---|
Katalog-ID: |
ELV049669370 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV049669370 | ||
003 | DE-627 | ||
005 | 20230626024909.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200518s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S0929-693X(20)30047-6 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica |
035 | |a (DE-627)ELV049669370 | ||
035 | |a (ELSEVIER)S0929-693X(20)30047-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |a 530 |q VZ |
084 | |a 33.00 |2 bkl | ||
100 | 1 | |a Pagin, A. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
264 | 1 | |c 2020transfer abstract | |
300 | |a 5 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. | ||
520 | |a Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. | ||
650 | 7 | |a CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) |2 Elsevier | |
650 | 7 | |a Cystic fibrosis transmembrane conductance regulator (CFTR) |2 Elsevier | |
650 | 7 | |a CFTR-related disorders (CFTR-RD) |2 Elsevier | |
650 | 7 | |a Cystic fibrosis (CF) |2 Elsevier | |
700 | 1 | |a Sermet-Gaudelus, I. |4 oth | |
700 | 1 | |a Burgel, P.-R. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Cui, Yuqiong ELSEVIER |t Archives de pédiatrie |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV006498205 |
773 | 1 | 8 | |g volume:27 |g year:2020 |g pages:25-29 |g extent:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/S0929-693X(20)30047-6 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 33.00 |j Physik: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 27 |j 2020 |h 25-29 |g 5 |y 27.2020, eS25-, (5 S.) |
author_variant |
a p ap |
---|---|
matchkey_str |
paginasermetgaudelusiburgelpr:2020----:eeidanssnrciermytcirssof |
hierarchy_sort_str |
2020transfer abstract |
bklnumber |
33.00 |
publishDate |
2020 |
allfields |
10.1016/S0929-693X(20)30047-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica (DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 DE-627 ger DE-627 rakwb eng 540 530 VZ 33.00 bkl Pagin, A. verfasserin aut Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders 2020transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier Sermet-Gaudelus, I. oth Burgel, P.-R. oth Enthalten in Elsevier Cui, Yuqiong ELSEVIER Archives de pédiatrie 2021 Amsterdam [u.a.] (DE-627)ELV006498205 volume:27 year:2020 pages:25-29 extent:5 https://doi.org/10.1016/S0929-693X(20)30047-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.00 Physik: Allgemeines VZ AR 27 2020 25-29 5 27.2020, eS25-, (5 S.) |
spelling |
10.1016/S0929-693X(20)30047-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica (DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 DE-627 ger DE-627 rakwb eng 540 530 VZ 33.00 bkl Pagin, A. verfasserin aut Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders 2020transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier Sermet-Gaudelus, I. oth Burgel, P.-R. oth Enthalten in Elsevier Cui, Yuqiong ELSEVIER Archives de pédiatrie 2021 Amsterdam [u.a.] (DE-627)ELV006498205 volume:27 year:2020 pages:25-29 extent:5 https://doi.org/10.1016/S0929-693X(20)30047-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.00 Physik: Allgemeines VZ AR 27 2020 25-29 5 27.2020, eS25-, (5 S.) |
allfields_unstemmed |
10.1016/S0929-693X(20)30047-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica (DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 DE-627 ger DE-627 rakwb eng 540 530 VZ 33.00 bkl Pagin, A. verfasserin aut Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders 2020transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier Sermet-Gaudelus, I. oth Burgel, P.-R. oth Enthalten in Elsevier Cui, Yuqiong ELSEVIER Archives de pédiatrie 2021 Amsterdam [u.a.] (DE-627)ELV006498205 volume:27 year:2020 pages:25-29 extent:5 https://doi.org/10.1016/S0929-693X(20)30047-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.00 Physik: Allgemeines VZ AR 27 2020 25-29 5 27.2020, eS25-, (5 S.) |
allfieldsGer |
10.1016/S0929-693X(20)30047-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica (DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 DE-627 ger DE-627 rakwb eng 540 530 VZ 33.00 bkl Pagin, A. verfasserin aut Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders 2020transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier Sermet-Gaudelus, I. oth Burgel, P.-R. oth Enthalten in Elsevier Cui, Yuqiong ELSEVIER Archives de pédiatrie 2021 Amsterdam [u.a.] (DE-627)ELV006498205 volume:27 year:2020 pages:25-29 extent:5 https://doi.org/10.1016/S0929-693X(20)30047-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.00 Physik: Allgemeines VZ AR 27 2020 25-29 5 27.2020, eS25-, (5 S.) |
allfieldsSound |
10.1016/S0929-693X(20)30047-6 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica (DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 DE-627 ger DE-627 rakwb eng 540 530 VZ 33.00 bkl Pagin, A. verfasserin aut Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders 2020transfer abstract 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier Sermet-Gaudelus, I. oth Burgel, P.-R. oth Enthalten in Elsevier Cui, Yuqiong ELSEVIER Archives de pédiatrie 2021 Amsterdam [u.a.] (DE-627)ELV006498205 volume:27 year:2020 pages:25-29 extent:5 https://doi.org/10.1016/S0929-693X(20)30047-6 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.00 Physik: Allgemeines VZ AR 27 2020 25-29 5 27.2020, eS25-, (5 S.) |
language |
English |
source |
Enthalten in Archives de pédiatrie Amsterdam [u.a.] volume:27 year:2020 pages:25-29 extent:5 |
sourceStr |
Enthalten in Archives de pédiatrie Amsterdam [u.a.] volume:27 year:2020 pages:25-29 extent:5 |
format_phy_str_mv |
Article |
bklname |
Physik: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Cystic fibrosis transmembrane conductance regulator (CFTR) CFTR-related disorders (CFTR-RD) Cystic fibrosis (CF) |
dewey-raw |
540 |
isfreeaccess_bool |
false |
container_title |
Archives de pédiatrie |
authorswithroles_txt_mv |
Pagin, A. @@aut@@ Sermet-Gaudelus, I. @@oth@@ Burgel, P.-R. @@oth@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
ELV006498205 |
dewey-sort |
3540 |
id |
ELV049669370 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049669370</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626024909.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0929-693X(20)30047-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049669370</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0929-693X(20)30047-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pagin, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis transmembrane conductance regulator (CFTR)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CFTR-related disorders (CFTR-RD)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis (CF)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sermet-Gaudelus, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burgel, P.-R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Cui, Yuqiong ELSEVIER</subfield><subfield code="t">Archives de pédiatrie</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006498205</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:25-29</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0929-693X(20)30047-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.00</subfield><subfield code="j">Physik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2020</subfield><subfield code="h">25-29</subfield><subfield code="g">5</subfield><subfield code="y">27.2020, eS25-, (5 S.)</subfield></datafield></record></collection>
|
author |
Pagin, A. |
spellingShingle |
Pagin, A. ddc 540 bkl 33.00 Elsevier CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
authorStr |
Pagin, A. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV006498205 |
format |
electronic Article |
dewey-ones |
540 - Chemistry & allied sciences 530 - Physics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
540 530 VZ 33.00 bkl Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) Elsevier |
topic |
ddc 540 bkl 33.00 Elsevier CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) |
topic_unstemmed |
ddc 540 bkl 33.00 Elsevier CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) |
topic_browse |
ddc 540 bkl 33.00 Elsevier CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID) Elsevier Cystic fibrosis transmembrane conductance regulator (CFTR) Elsevier CFTR-related disorders (CFTR-RD) Elsevier Cystic fibrosis (CF) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
i s g isg p r b prb |
hierarchy_parent_title |
Archives de pédiatrie |
hierarchy_parent_id |
ELV006498205 |
dewey-tens |
540 - Chemistry 530 - Physics |
hierarchy_top_title |
Archives de pédiatrie |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV006498205 |
title |
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
ctrlnum |
(DE-627)ELV049669370 (ELSEVIER)S0929-693X(20)30047-6 |
title_full |
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
author_sort |
Pagin, A. |
journal |
Archives de pédiatrie |
journalStr |
Archives de pédiatrie |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
25 |
author_browse |
Pagin, A. |
container_volume |
27 |
physical |
5 |
class |
540 530 VZ 33.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Pagin, A. |
doi_str_mv |
10.1016/S0929-693X(20)30047-6 |
dewey-full |
540 530 |
title_sort |
genetic diagnosis in practice: from cystic fibrosis to cftr-related disorders |
title_auth |
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
abstract |
Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. |
abstractGer |
Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. |
abstract_unstemmed |
Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
title_short |
Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders |
url |
https://doi.org/10.1016/S0929-693X(20)30047-6 |
remote_bool |
true |
author2 |
Sermet-Gaudelus, I. Burgel, P.-R. |
author2Str |
Sermet-Gaudelus, I. Burgel, P.-R. |
ppnlink |
ELV006498205 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth |
doi_str |
10.1016/S0929-693X(20)30047-6 |
up_date |
2024-07-06T22:13:23.490Z |
_version_ |
1803869490764578816 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049669370</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626024909.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0929-693X(20)30047-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000952.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049669370</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0929-693X(20)30047-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pagin, A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CFTR-related metabolic syndrome(CRMS)/CF screen positive inconclusive diagnosis (CFSPID)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis transmembrane conductance regulator (CFTR)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CFTR-related disorders (CFTR-RD)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis (CF)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sermet-Gaudelus, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burgel, P.-R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Cui, Yuqiong ELSEVIER</subfield><subfield code="t">Archives de pédiatrie</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006498205</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:25-29</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0929-693X(20)30047-6</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.00</subfield><subfield code="j">Physik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2020</subfield><subfield code="h">25-29</subfield><subfield code="g">5</subfield><subfield code="y">27.2020, eS25-, (5 S.)</subfield></datafield></record></collection>
|
score |
7.4017324 |